Instructors
Policy on Disclosure
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.
For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients.
John Dopp, PharmD, MS, Associate Professor, School of Pharmacy, University of Wisconsin – Madison
Financial Relationship Disclosure: Relypsa Pharmaceuticals (Contractor)
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: Yes
Barry Gidal, PharmD, RPh, FAES, Professor, School of Pharmacy, University of Wisconsin – Madison
Financial Relationship Disclosure: Greenwich (Contractor), Eisai (Contractor), UCB (Grant), Sunovion (Contractor)
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: No
Sara Hassan, BPharm, MS, PhD, School of Pharmacy, University of Wisconsin – Madison
Financial Relationship Disclosure: No financial relationships with ineligible companies to disclose
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: Yes
Paul Hutson, PharmD, Professor, School of Pharmacy, University of Wisconsin – Madison
Financial Relationship Disclosure: Patel Kwon, Projections, LLC (Contractor)
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: Yes
Angela Janis, MD, DFAPA, Psychiatrist, Mendota Mental Health Institute
Financial Relationship Disclosure: No financial relationships with ineligible companies to disclose
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: No
Hunter Land, MS, Associate Director, Cannabinoid Research at Canopy Growth Corporation
Financial Relationship Disclosure: Canopy Growth Corporation (Employee)
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: No
David Potter, JP, PhD, FRSB, FLS, Director of Botanical Research, GW Pharmaceuticals
Financial Relationship Disclosure: GW Pharmaceuticals (Employee)
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: No
Lucas Richert, PhD, Associate Professor, George Urdang Chair in the History of Pharmacy, School of Pharmacy, University of Wisconsin – Madison
Financial Relationship Disclosure: No financial relationships with ineligible companies to disclose
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: Yes
Natalie Schmitz, MPA, PharmD, PhD, Assistant Professor, School of Pharmacy, University of Wisconsin – Madison
Financial Relationship Disclosure: No financial relationships with ineligible companies to disclose
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: Yes
Cody Wenthur, PharmD, PhD, Assistant Professor, School of Pharmacy, University of Wisconsin – Madison
Financial Relationship Disclosure: No financial relationships with ineligible companies to disclose
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: Yes
Planning Committee
Leslie Dickmann, PhD, MPH, Program Director, School of Pharmacy, University of Wisconsin – Madison
Financial Relationship Disclosure: No financial relationships with ineligible companies to disclose
Discussion of Unlabeled/Unapproved Uses of Drugs/Devices in Presentation: No
Barry Gidal, PharmD, RPh, FAES, Professor, School of Pharmacy, University of Wisconsin – Madison
Disclosure: see above
Angela Janis, MD, DFAPA, Psychiatrist, Mendota Mental Health Institute
Disclosure: see above
Natalie Schmitz, MPA, PharmD, PhD, Assistant Professor, School of Pharmacy, University of Wisconsin – Madison
Disclosure: see above
CE Credit
Accreditation Statements
In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
|
Credit Designation Statements
Accreditation Council for Pharmacy Education (ACPE)
The University of Wisconsin-Madison ICEP designates this enduring knowledge-based activity for 13.5 hours (1.35 CEUs) of CPE credit. Credit can be earned by successfully completing the assessment (70% or better score) and evaluation. There will be no partial credit awarded for partial completion.
Enduring (home study):
Lecture 1: JA0000358-0000-20-087-H04-P 1.0 hours (0.1 CEUs)
Lecture 2: JA0000358-0000-20-088-H04-P 0.5 hours (0.05 CEUs)
Lecture 3: JA0000358-0000-20-089-H04-P 1.5 hours (0.15 CEUs)
Lecture 4: JA0000358-0000-20-090-H04-P 1.0 hours (0.1 CEUs)
Lecture 5: JA0000358-0000-20-091-H04-P 0.75 hours (0.075 CEUs)
Lecture 6: JA0000358-0000-20-092-H04-P 1.5 hours (0.15 CEUs)
Lecture 7: JA0000358-0000-20-093-H04-P 1.0 hours (0.1 CEUs)
Lecture 8: JA0000358-0000-20-094-H04-P 1.0 hours (0.1 CEUs)
Lecture 9: JA0000358-0000-20-095-H04-P 1.25 hours (0.125 CEUs)
Lecture 10: JA0000358-0000-20-096-H04-P 0.5 hours (0.05 CEUs)
Lecture 11: JA0000358-0000-20-097-H08-P 1.5 hours (0.15 CEUs)
Lecture 12: JA0000358-0000-20-098-H08-P 1.0 hours (0.10 CEUs)
Lecture 13: JA0000358-0000-20-099-H04-P 1.0 hours (0.1 CEUs)
Release Date: 07/15/2020 Expiration Date: 07/15/2023
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this enduring activity for a maximum of 13.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Education Units (CEUs)
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 1.35 CEUs or 13.5 hours.